Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma

By Irie Reiko   Ollila David   O’Day Steven   Morton Donald  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 2, 2004-02 ,pp. : 110-117

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma

By Hersey Peter   Menzies Scott   Halliday Gary   Nguyen Tam   Farrelly Margaret   DeSilva Chitra   Lett Margaret  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 2, 2004-02 ,pp. : 125-134

Springer Publishing Company

Access to resources Recommend Favorite

Vaccination with HPV16 Peptides of Patients with Advanced Cervical Carcinoma: Clinical Evaluation of a Phase I-II Trial

By van Driel W.J.   Ressing M.E.   Kenter G.G.   Brandt R.M.P.   Krul E.J.T.   van Rossum A.B.   Schuuring E.   Offringa R.   Bauknecht T.   Tamm-Hermelink A.   van Dam P.A.   Fleuren G.J.   Kast W.M.   Melief C.J.M.   Trimbos J.B.  

European Journal of Cancer, Vol. 35, Iss. 6, 1999-06 ,pp. : 946-952

Elsevier

Access to resources Recommend Favorite

Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial

By van Poznak C.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 3, 2001-04 ,pp. : 239-248

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma

By Hainsworth John D.   Infante Jeffrey R.   Spigel David R.   Arrowsmith Edward R.   Boccia Ralph V.   Burris Howard A.  

Cancer Investigation, Vol. 29, Iss. 7, 2011-07 ,pp. : 451-455

Informa Healthcare

Access to resources Recommend Favorite